SEC Form 4 · accession 0000899243-18-013255
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean Maduck
Officer — See Remarks
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2018 | M | 10,000 | $2.24 | A | 20,024 | D | |
| Common StockF1 | holding | — | — | — | 10,000 | I | See Footnote | |
| Common StockF2 | holding | — | — | — | 10,000 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $2.24 | May 15, 2018 | M | 10,000 | D | — | Nov 1, 2022 | Common Stock | 10,000 | 35,000 | D |
Explanation of responses
- F1Represents the shares held by Duckhill Capital, LLC of which the reporting person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- F2Represents the shares held by Sean and Molly Maduck Living Trust of which the reporting person is a co-trustee.
- F3Fully exercisable.
Remarks
Senior Vice President, Commercial